[
  {
    "ts": "2026-02-19T05:37:55+00:00",
    "headline": "5 Insightful Analyst Questions From West Pharmaceutical Services’s Q4 Earnings Call",
    "summary": "West Pharmaceutical Services’ fourth quarter results reflected robust demand for its high-value product components, particularly those tied to biologics and GLP-1 therapies. Management highlighted that non-GLP-1 high-value products also saw improving trends, with CEO Eric Green noting a “strong recovery throughout the year to align to the market demand.” The company benefited from a favorable product mix, as high-value products drove margin expansion despite some headwinds from increased R&D and",
    "url": "https://finance.yahoo.com/news/5-insightful-analyst-questions-west-053755605.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "a4adeebc-3baa-3f4f-9f82-7889f934164f",
      "content": {
        "id": "a4adeebc-3baa-3f4f-9f82-7889f934164f",
        "contentType": "STORY",
        "title": "5 Insightful Analyst Questions From West Pharmaceutical Services’s Q4 Earnings Call",
        "description": "",
        "summary": "West Pharmaceutical Services’ fourth quarter results reflected robust demand for its high-value product components, particularly those tied to biologics and GLP-1 therapies. Management highlighted that non-GLP-1 high-value products also saw improving trends, with CEO Eric Green noting a “strong recovery throughout the year to align to the market demand.” The company benefited from a favorable product mix, as high-value products drove margin expansion despite some headwinds from increased R&D and",
        "pubDate": "2026-02-19T05:37:55Z",
        "displayTime": "2026-02-19T05:37:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/0a7131c3c60abde7f623f12aa0840d12",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "WST Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sSo4Y0O6fK3srLaBp2GOtw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/0a7131c3c60abde7f623f12aa0840d12.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/65j8gZhdqmvJSKJWauAyCA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/0a7131c3c60abde7f623f12aa0840d12.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-insightful-analyst-questions-west-053755605.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-insightful-analyst-questions-west-053755605.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]